Log in to your Inderes Free account to see all free content on this page.
AcuCort
0.69 SEK
-0.86 %
Less than 1K followers
ACUC
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.86 %
+8.44 %
-23.15 %
+15.67 %
+11.94 %
-3.34 %
-26.41 %
-77.52 %
-72.81 %
AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.
Read moreMarket cap
162.7M SEK
Turnover
134.26K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.5.
2026
General meeting '26
12.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
AcuCort AB: AcuCort and the FDA agree on iPSP - important step towards US market approval
AcuCort AB: AcuCort publishes newsletter with CEO update
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio